Belanoff Joseph K

Avg. Two Year Performance

No purchase track record
(40%) Avg. Sale Return
(19%) Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return----------
Purchase Success Rate----------
Average Sale Return12%16%8%(54%)(40%)
Sale Success Rate16 of 2416 of 2415 of 2417 of 2419 of 24
Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 3.02M shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--